» Articles » PMID: 38155610

Growth, Body Composition, and Endocrine-metabolic Profiles of Individuals with Kleefstra Syndrome Provide Directions for Clinical Management and Translational Studies

Overview
Specialty Genetics
Date 2023 Dec 29
PMID 38155610
Authors
Affiliations
Soon will be listed here.
Abstract

Mendelian neurodevelopmental disorders caused by variants in genes encoding chromatin modification can be categorized as Mendelian disorders of the epigenetic machinery (MDEMs). These disorders have significant overlap in molecular pathways and phenotypes including intellectual disability, short stature, and obesity. Among the MDEMs is Kleefstra syndrome (KLFS), which is caused by haploinsufficiency of EHMT1. Preclinical studies have identified metabolic dysregulation and obesity in KLFS models, but proper clinical translation lacks. In this study, we aim to delineate growth, body composition, and endocrine-metabolic characteristics in a total of 62 individuals with KLFS. Our results revealed a high prevalence of childhood-onset overweight/obesity (60%; 28/47) with disproportionately high body fat percentage, which aligns perfectly with previous preclinical studies. Short stature was common (33%), likely due to advanced skeletal maturation. Endocrine-metabolic investigations showed thyroid dysregulation (22%; 9/41), elevated triglycerides, and decreased blood ammonia levels. Moreover, hand radiographs identified decreased bone mineralization (57%; 8/14) and negative ulnar variance (71%; 10/14). Our findings indicate a high (cardio)metabolic risk in KLFS. Therefore, we recommend monitoring of weight and endocrine-metabolic profile. Supporting a healthy lifestyle and screening of bone mineralization is advised. Our comprehensive results support translational research and contribute to a better understanding of MDEM-associated phenotypes.

Citing Articles

The expanding landscape of genetic causes of obesity.

Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V Pediatr Res. 2024; .

PMID: 39690244 DOI: 10.1038/s41390-024-03780-6.


Establishment of human pluripotent stem cell-derived cortical neurosphere model to study pathomechanisms and chemical toxicity in Kleefstra syndrome.

Balogh A, Bodi-Jakus M, Karl V, Bellak T, Szeky B, Farkas J Sci Rep. 2024; 14(1):22572.

PMID: 39343771 PMC: 11439915. DOI: 10.1038/s41598-024-72791-4.


Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome.

Rots D, Bouman A, Yamada A, Levy M, Dingemans A, de Vries B Am J Hum Genet. 2024; 111(8):1605-1625.

PMID: 39013458 PMC: 11339614. DOI: 10.1016/j.ajhg.2024.06.008.

References
1.
McPartland J . Considerations in biomarker development for neurodevelopmental disorders. Curr Opin Neurol. 2016; 29(2):118-22. PMC: 4798424. DOI: 10.1097/WCO.0000000000000300. View

2.
Vermeulen K, de Boer A, Janzing J, Koolen D, Ockeloen C, Willemsen M . Adaptive and maladaptive functioning in Kleefstra syndrome compared to other rare genetic disorders with intellectual disabilities. Am J Med Genet A. 2017; 173(7):1821-1830. DOI: 10.1002/ajmg.a.38280. View

3.
Sheppard S, Campbell I, Harr M, Gold N, Li D, Bjornsson H . Expanding the genotypic and phenotypic spectrum in a diverse cohort of 104 individuals with Wiedemann-Steiner syndrome. Am J Med Genet A. 2021; 185(6):1649-1665. PMC: 8631250. DOI: 10.1002/ajmg.a.62124. View

4.
Maia N, Nabais Sa M, Melo-Pires M, de Brouwer A, Jorge P . Intellectual disability genomics: current state, pitfalls and future challenges. BMC Genomics. 2021; 22(1):909. PMC: 8686650. DOI: 10.1186/s12864-021-08227-4. View

5.
Mergler S, de Man S, Boot A, Bindels-de Heus K, Huijbers W, van Rijn R . Automated radiogrammetry is a feasible method for measuring bone quality and bone maturation in severely disabled children. Pediatr Radiol. 2016; 46(7):1017-22. PMC: 4883271. DOI: 10.1007/s00247-016-3548-4. View